Categories
Market Reports Market Study News

Gene Therapy Market Industry Growth With High CAGR During Forecast 2020 | Covid-19 Impact

The Business Research Company’s Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change. The report covers market size, key players, market share and trends to 2030.

Gene Therapy Market Global Report 2020-30: Covid 19 Growth and Change is one of a series of new reports from The Business Research Company that provide Gene Therapy market overviews, analyze and forecast market size and growth for the whole market, Gene Therapy market segments and geographies, Gene Therapy market trends, Gene Therapy market geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read More On The Gene Therapy Market Here –
https://www.thebusinessresearchcompany.com/report/gene-therapy-market-global-report-2020-30-covid-19-growth-and-change

The gene therapy market consists of sales of gene therapy related services by entities (organizations, sole traders and partnerships) that manufacture gene therapy drugs. Gene therapy is used to replace faulty genes or add new genes to cure disease or improve the body`s ability to fight disease. Only goods and services traded between entities or sold to end consumers are included.

Request A Sample For The Gene Therapy Market Report Now –
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

The global gene therapy market is expected to decline from $3.22 billion in 2019 to $3.18 billion in 2020 at a compound annual growth rate (CAGR) of -1.30%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The market is then expected to recover and reach $6.84 billion in 2023 at a CAGR of 29.09%.

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_Info

Categories
News

Gene Therapy Market to Witness Huge Growth in The Future | Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon

The latest market study on the global Gene Therapy market with data Tables, Pie Chart & Graphs is released by Market Intellica that will provide a complete assessment of the market and covers developing trends, current situation analysis, and development factors, and industry-validated market data. Some are the key players from the coverage that are also part of the study are Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene.

Click to get global Gene Therapy market research sample PDF copy here @ https://www.marketintellica.com/report/MI83853-gene-therapy-market-research-global-status#enquiry

Key highlights of the report:

  • How Companies are profiled in the report?

    A complete valuation is done on a list of companies taken into consideration by following certain industry standards like NAICS, ICB, etc. to reach the most relevant profile or manufacturers. More importance is given on SMEs that are emerging, and evolving in the market with their product presence and industrial upgraded modes, players that are also part of study taken from a vast list of coverage are Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene, and many more.

  • You can directly purchase the Gene Therapy report using this secure link: https://www.marketintellica.com/checkout/MI83853-gene-therapy-market-research-global-status

  • Can we add or profiled a new company or customize a list of companies in the final study?

    Yes, we can add or profile a new company as per client needs in the final report. Final confirmation will be provided by the research team depending upon the difficulty of the survey.

  • Any Value Addition Chapters to Provide out of box Assessment?

    Market Entropy: It will provide the randomness of the market which will help you understand the market’s aggressiveness; players constantly do expansions, technological advancement, M&A, joint ventures. Patent Study: To overcome competition, players constantly make R&D expenses, and to better appraise the uncertain growth situation of market players and overall industry a patent analysis chapter introduces which will provide insights like no. of patents issued by players each year. Peer Study: A evaluation of peer to peer analysis by key financial metrics such as EBITDA Margin, Net Profit Margin, Gross Margin, Total Revenue, Segmented Market Share, Assets, etc.

    Browse for Full Report at @: https://www.marketintellica.com/report/MI83853-gene-therapy-market-research-global-status

  • What details will the competitive landscape will provide?

    Value proposal chapters to help you understand what level of business tactics key players are involved along with investment, and deal size to measure the market. 2-Page profiles for all listed manufacturers along with 3 years of financial data to evaluate their overall performance in the market along with business overview, product description, headquarter details, etc.

  • What all county segmentation covered? Can a specific country of interest be added?

    Currently, the research report gives special attention, and focus on the following regions: United States, Europe, China, Japan, Southeast Asia, India & Central & South America.
    ** Countries of specific interest can be included as per Clients Requirement.

To understand Global Gene Therapy market dynamics in the world mainly, the worldwide Gene Therapy market is analyzed across major global regions. MI also provides customized specific regional and country-level reports for the following areas.

  1. North America: United States, Canada, and Mexico.
  2. South & Central America: Argentina, Chile, and Brazil.
  3. Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt, and South Africa.
  4. Europe: UK, France, Italy, Germany, Spain, and Russia.
  5. Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.

Enquire for customization in Report: https://www.marketintellica.com/report/MI83853-gene-therapy-market-research-global-status#customization

Core segmentation details:

  1. Global Gene Therapy Product Types In-Depth:
    • Ex vivo
    • In vivo
    • Others
  2. Gene Therapy market

  3. Global Gene Therapy Major Applications/End users:
    • Cancer Diseases
    • Monogenic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others
  4. Gene Therapy market

  5. Geographical Analysis: United States, Europe, China, Japan, Southeast Asia, India & Central & South America

Buy full copy global Gene Therapy Report 2020 @ Gene Therapy

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report. Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia.

About Us:

Market Intellica (MI) provides market research reports on various categories such as chemicals, green energy, manufacturing, machinery, pharmaceuticals, materials, and many more. We are a one-stop solution for market reports published by most of the leading publishers, that are easy-to-access, updated with new and emerging technology in the market, and with a global industry coverage. We assist companies and their executives to make better, faster, reliable, and effective decisions with market reports and data-driven market insights.

Contact Us:
Anna L
Sr. Engagement Partner
MarketIntellica
sales(at)marketintellica(dot)com
info(at)marketintellica(dot)com
https://twitter.com/IntellicaMarket
https://www.facebook.com/marketintellica/

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size

Gene Therapy Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

Polaris Market Research recently updated its existing market research study on the Gene Therapy Market and estimates that the market would reach USD 4,300 million by 2021. The report provides historical data along with forecast till 2026. The report covers market trends, drivers and opportunity analysis and provides competitor benchmarking information. The report covers an exhaustive list of market tables and figures, thus providing in-depth analytical data for segments across different regions.

The updated report on the Gene Therapy Market is segmented by Therapeutics and by Regions. Major companies covered in the report include:

  • Novartis Pharmaceuticals Corporation
  • Kite Pharma, Incorporated
  • Spark Therapeutics, Inc
  • GlaxoSmithKline
  • Adaptimmune
  • Bluebird bio
  • Celgene
  • Shanghai Sunway Biotech
  • Shenzhen SiBiono GeneTech
  • SynerGene Therapeutics

For more information, request a sample of the study on https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

The study evaluates the overall Gene Therapy Market by the following segments:

  • Historical Marketed Gene Therapies [2003-2012]
    • Rexin-G (Epeius Biotechnologies Corporation)
    • Gendicine (SiBiono GeneTech Co., Ltd)
    • Neovasculgen [Human Stem Cells Institute (HSCI))
    • Glybera (UniQure Biopharma B.V.)
  • First Countries to get an access to Gene Therapies
    • Philippines for Rexin-G [2003]
    • China for Gendicine [2003]
    • Russia for Neovasculgen [2011]
    • Selected European Countries for Glybera

The report attributes are as follows:

  • Historical Data (Actuals): 2015, 2016, 2017
  • Base Year: 2016
  • Estimates & Forecast: 2019 to 2021

The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:

  • Industry Trends, opportunity and challenges in the market
  • Role of key players across the value chain
  • End-User analysis to define the market strategy
  • Competitive mapping
  • Regional and country level breakdown

These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/speak-to-analyst

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact Us

Polaris Market Research

Phone: +44-203-287-6050

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

Gene Therapy Market is Projected to Expand at a CAGR of 40.0% from 2018 to 2026

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Purchase Gene Therapy Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

More Trending Reports by Transparency Market Research –

Fetal Monitoring Systems Market: https://www.prnewswire.com/news-releases/innovation-in-wearable-devices-driving-fetal-monitoring-systems-market-to-upward-growth-trajectory-tmr-301015185.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Categories
Analysis Forecast Coronavirus COVID-19 Industry Impact Market Size

Gene Therapy Market Future Forecast Assessed On The Basis Of How The Market Is Predicted To Grow

According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us

Mr. Likhil

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
Analysis Forecast Market Price Analysis Market Reports Market Size News

Gene Therapy Market Growth, SWOT Analysis by Top Vendors and Forecast Report to 2028

Quince Market Insights has recently released a market report which provides an in-depth understanding of various drivers and opportunities that are expected to shape the development of a market for Gene therapy . This report highlights further the structure of the Gene therapy market in several regions and analyzes the business environment in individual regions.

The research report for global Gene therapy market consists of the valuation for a period from 2020 to 2028. The global study on Gene therapy also provides qualitative industry perspectives such as engines, barriers, value chain, regulatory framework and trade statistics. The supply chain of main stages has been studied in depth.

For more information, download sample of the premium report https://www.quincemarketinsights.com/request-sample-60261?utm_source=campaign=Pooja/PF

Quince Market Insights | LinkedIn

The size of the global Gene therapy market is expected to reach USD xxx billion by 2028. During the forecast period, the global Gene therapy market is expected to expand at an x.x per cent CAGR.

In order to provide a deep understanding of different aspects of the Gene therapy market at the granular level, the Gene therapy market is split into several segments. The report illustrates each segment and sub-segment’s growth potential, market size, share, and future prospects.

The report thoroughly discusses important indicators of market growth, such as the analysis of the supply chain, value chain analysis and a compounded annual growth rate. The data presented will allow readers to understand in detail the quantitative and qualitative growth aspects of the Gene therapy market.

Alliance for Regenerative Medicine, Gilead Sciences, Inc., Novartis AG, Sibiono GeneTech Co. Ltd.and others are among the world’s leading players in the Gene therapy business. Such businesses harness the technological advances to extend their product reach and widen their choice of customers. To increase their versatility and willingness to adapt products to customer feedback, businesses are making use of technology to become more customer-centric.

Benefits of this report are-

    • It offers value for competitive level playing, giving the current giants as well as new entries equal status.

    • It will raise understanding of Gene therapy market’s overall outlook.

    • It is a strategic marketing approach to raise organisation, which makes it a totally helpful report, among other competitors.

    • -Helps to understand the current market scenario, as the report gives historical information on the space of the Gene therapy and makes future projections.

    • -The customized market segments will be examined depending on the region, country or even the different manufacturers in the Gene therapy .

Get ToC for the overview of the premium report https://www.quincemarketinsights.com/request-toc-60261?utm_source=campaign=Pooja/PF

Market Segmentation:

By Product:

• Yescarta

• Kymriah

• Luxturna

• Strimvelis

• Gendicine

By Application:

• Ophthalmology

• Oncology

• Adenosine

• Deaminase

• Deficient Severe Combined Immunodeficiency

By Region:

• North America

◦ North America, by Country

▪ US

▪ Canada

▪ Mexico

◦ North America, by Product

◦ North America, by Application

• Western Europe

◦ Western Europe, by Country

▪ Germany

▪ UK

▪ France

▪ Italy

▪ Spain

▪ The Netherlands

▪ Rest of Western Europe

◦ Western Europe, by Product

◦ Western Europe, by Application

• Asia Pacific

◦ Asia Pacific, by Country

▪ China

▪ India

▪ Japan

▪ South Korea

▪ Australia

▪ Indonesia

▪ Rest of Asia Pacific

◦ Asia Pacific, by Product

◦ Asia Pacific, by Application

• Eastern Europe

◦ Eastern Europe, by Country

▪ Russia

▪ Turkey

▪ Rest of Eastern Europe

◦ Eastern Europe, by Product

◦ Eastern Europe, by Application

• Middle East

◦ Middle East, by Country

▪ UAE

▪ Saudi Arabia

▪ Qatar

▪ Iran

▪ Rest of Middle East

◦ Middle East, by Product

◦ Middle East, by Application

• Rest of the World

◦ Rest of the World, by Country

▪ South America

▪ Africa

◦ Rest of the World, by Product

◦ Rest of the World, by Application

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us

Quince Market Insights
Ajay D. (Knowledge Partner)
Office No- A109,
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986
Email: [email protected]
Web: www.quincemarketinsights.com

Categories
News

Gene Therapy Market Boosting the Healthcare Industry Worldwide

Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global gene therapy market was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during the forecast period. The high growth rate is attributed to the anticipated approval and commercialization of gene therapy products in developed countries such as Japan, Australia & New Zealand, GCC countries, and China, and high prevalence of non-Hodgkin Lymphoma and head and neck cancers.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1838

New product approvals & commercialization drives market

2016, 2017, and 2018 were key milestones in the history of the gene therapy market in the U.S. and Europe, as around four gene therapy products have been approved and commercialized. These products are currently in the infancy stage of commercialization, and have exhibited highly positive therapeutic outcomes. For instance, in May 2016, GlaxoSmithKline (GSK) gene therapy product, Strimvelis, received marketing approval for the treatment of patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency, due to Adenosine Deaminase deficiency). Strimvelis is the first ex-vivo stem cell gene therapy to be approved in Europe for the treatment of ADA-SCID. Furthermore, in August 2017, the USFDA approved Novartis AG’s flagship gene therapy product, Kymriah, for the treatment of children and adults up to the age of 25 years affected with B-cell precursor acute lymphoblastic leukemia (ALL). Thus, recent approvals of gene therapy products in the U.S. and Europe for the treatment of various life threatening disorders is projected to fuel the gene therapy market during the forecast period.

Yescarta to be highest revenue generating gene therapy product

The report offers a detailed segmentation of the global gene therapy market based on different gene therapy products approved and commercialized. Based on product, the global gene therapy market has been segmented into Yescarta, Kymriah, Luxturna, Strimvelis, and Gendicine. Yescarta (Axicabtagene Ciloleucel) is a genetically modified autologous Chimeric Antigen Receptor T (CAR T) cell immunotherapy developed by Gilead Sciences, Inc. for the treatment of adult patients with relapsed or refractory large B-cell lymphoma including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL). It is the first CAR T therapy approved by the US FDA for the treatment of DLBCL. The Yescarta segment is projected to dominate the global gene therapy market by the end of 2026. Anticipated commercialization of Yescarta in Europe and other developed countries and increasing number of treatment centers are key factors that are likely to lead to the dominant share held by Yescarta by the end of 2026.

Request for Analysis of COVID19 Impact on Gene Therapy Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1838

Oncology segment to account for high market share

In terms of application, the global gene therapy market has been segmented into ophthalmology, oncology, and adenosine deaminase ?deficient severe combined immunodeficiency (ADA-SCID). The oncology segment is likely to account for a significant share of the market by the end of 2026. Oncology is a highly studied medical field in the clinical pipeline studies of gene therapy candidates. More than 60% of gene therapy clinical research studies are focused on oncology. The large share held by the oncology segment is attributed to the approval and commercialization of Yescarta and Kymriah, in the last one to two years, for the treatment of certain types of non-Hodgkin lymphoma in the U.S. and Europe. Furthermore, increase in demand for Gendicine in China for the treatment of head and neck cancers is projected to drive the segment during the forecast period.

Europe offers high incremental opportunity

The gene therapy market in Europe is projected to expand at a significant CAGR of 30.6% during the forecast period. Large number of patient population with refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), promising therapeutic outcomes, rising demand for gene therapy treatment, and increasing number of gene therapy treatment centers in Europe are key factors that are likely to fuel the gene therapy market in Europe. Moreover, different pricing models are being evaluated by payers and governments to enable access to high priced gene therapy products. This is likely to drive the demand for gene therapy products in Europe during the forecast period.

Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1838

Large number of clinical pipeline studies and significant investments in gene therapy to gain the first mover advantage

The global gene therapy market is highly consolidated, with very few global players accounting for a major share. Currently, only five companies; Gilead life Sciences Inc. Spark Therapeutic Inc., Novartis AG, Sibiono GeneTech Co. Ltd, and Orchard Therapeutics Limited offer gene therapy products in the market. Most biopharmaceutical companies have invested significantly in clinical R&D for the development of gene therapy products for different chronic and genetic disorders. Large number of gene therapy products are under different stages of clinical pipeline studies, and the number of gene therapy candidates is projected to rise consistently during the forecast period. For instance, according to the Journal of Gene Medicine, there were around 2,597 gene therapy candidates under clinical trials, as of 2017. Of the total clinical studies, around 65% of studies were focused on oncology, 11% of studies were focused on monogenetic field, 7% on infectious diseases and cardiovascular disease, each.

Purchase Gene Therapy Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=1838&ltype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Read More Reports: https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html

 

Categories
Coronavirus Market Reports News

Gene Therapy Market: Detailed survey of the key competitors and the leading players

According to a new report published by Polaris Market Research, the global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need.

Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Request for sample copy of this report @  https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-sample

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.

Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Request for Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/gene-therapy-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us

Mr. Likhil

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

Categories
News

According to the Latest Report: Gene Therapy Market is Growing Massively with Leading Players – Kite Pharma, BioVex, Novartis, Spark Therapeutics

Gene Therapy Market Overview 2020 – 2025

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The rising technology in Gene Therapy Market is also depicted in this research report. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/59028

Key Competitors of the Global Gene Therapy Market are: , Kite Pharma, BioVex, Novartis, Spark Therapeutics

Historical data available in the report elaborates on the development of the Gene Therapy on national, regional and international levels. Gene Therapy Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis.

Major Product Types covered are:
Ex Vivo
In Vivo

Major Applications of Gene Therapy covered are:
Cancer Diseases
Hematological Disease
Hereditary Disease

This study report on global Gene Therapy market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities.

To get this report at a profitable rate.: https://reportsinsights.com/discount/59028

The fundamental purpose of Gene Therapy Market report is to provide a correct and strategic analysis of the Gene Therapy industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

Market Scenario:

The report further highlights the development trends in the global Gene Therapy market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Highlights following key factors:

:- Business description – A detailed description of the company’s operations and business divisions.
:- Corporate strategy – Analyst’s summarization of the company’s business strategy.
:- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
:- Company history – Progression of key events associated with the company.
:- Major products and services – A list of major products, services and brands of the company.
:- Key competitors – A list of key competitors to the company.
:- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
:- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Our report offers:

– Market share assessments for the regional and country level segments.
– Market share analysis of the top industry players.
– Strategic recommendations for the new entrants.
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets.
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).
– Strategic recommendations in key business segments based on the market estimations.
– Competitive landscaping mapping the key common trends.
– Company profiling with detailed strategies, financials, and recent developments.
– Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @   https://reportsinsights.com/industry-forecast/Gene-Therapy-Market-59028

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

 : (US) +1-214-272-0234

 : (APAC) +91-7972263819

Email: [email protected]

Sales: [email protected]

 

 

Categories
News

COVID-19 Impact on Gene Therapy Market Key Developments, Major Market Dynamics and Future Outlook 2024

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Gene Therapy

The New Report Titled: – Global Gene Therapy Market 2020 By Company, Regions, Type and Application, forecast to 2024; which mainly studies the size, recent trends and growth status of the Gene Therapy market, as well as share opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive background.

Get a Sample Copy of the Reporthttps://www.industryresearch.co/enquiry/request-sample/13856652

About Gene Therapy:

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson’s disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Major manufactures of Gene Therapy Industry:

  • Bluebird Bio
  • Sangamo
  • Spark Therapeutics
  • Dimension Therapeutics
  • Avalanche Bio
  • Celladon
  • Vical Inc.
  • Advantagene.

    To Understand How COVID-19 Impact is Covered in this Report on Gene Therapy Market

    Gene Therapy Market Segment by Type, covers:

  • Ex vivo
  • In Vivo

    Gene Therapy Market Segment by Applications can be divided into

  • Cancer
  • Monogenic
  • Infectious disease
  • Cardiovascular disease
  • Other

    Scope of Gene Therapy Report:

  • Gene therapy is a method that involves introducing genetic material into a person’s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.The global Gene Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
  • The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
  • North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy.
  • Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

    For More Information or Query or Customization Before Buying, Visit at- https://www.industryresearch.co/enquiry/pre-order-enquiry/13856652

    Detailed TOC of Global Gene Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024: Table of Contents

    1 Gene Therapy Market Overview

    1.1 Product Overview and Scope of Gene Therapy

    1.2 Classification of Gene Therapy by Types

    1.2.1 Global Gene Therapy Revenue Comparison by Types (2019-2024)

    1.2.2 Global Gene Therapy Revenue Market Share by Types in 2018

    1.3 Global Gene Therapy Market by Application

    1.3.1 Global Gene Therapy Market Size and Market Share Comparison by Applications (2014-2024)

    1.4 Global Gene Therapy Market by Regions

    1.4.1 Global Gene Therapy Market Size (Million USD) Comparison by Regions (2014-2024)

    1.4.1 North America (USA, Canada and Mexico) Gene Therapy Status and Prospect (2014-2024)

    1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy Status and Prospect (2014-2024)

    1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy Status and Prospect (2014-2024)

    1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy Status and Prospect (2014-2024)

    1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy Status and Prospect (2014-2024)

    1.5 Global Market Size of Gene Therapy (2014-2024)

    2 Manufacturers Profiles

    2.1 Company 1

    2.1.1 Business Overview

    2.1.2 Gene Therapy Type and Applications

    2.1.2.1 Product A

    2.1.2.2 Product B

    2.1.3 Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)

    2.2 Company 2

    2.2.1 Business Overview

    2.2.2 Gene Therapy Type and Applications

    2.2.2.1 Product A

    2.2.2.2 Product B

    2.2.3 Gene Therapy Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Gene Therapy Market Competition, by Players

    3.1 Global Gene Therapy Revenue and Share by Players (2014-2019)

    3.2 Market Concentration Rate

    3.2.1 Top 5 Gene Therapy Players Market Share

    3.2.2 Top 10 Gene Therapy Players Market Share

    3.3 Market Competition Trend

    4 Global Gene Therapy Market Size by Regions

    4.1 Global Gene Therapy Revenue and Market Share by Regions

    4.2 North America Gene Therapy Revenue and Growth Rate (2014-2019)

    4.3 Europe Gene Therapy Revenue and Growth Rate (2014-2019)

    4.4 Asia-Pacific Gene Therapy Revenue and Growth Rate (2014-2019)

    4.5 South America Gene Therapy Revenue and Growth Rate (2014-2019)

    4.6 Middle East and Africa Gene Therapy Revenue and Growth Rate (2014-2019)

    … and continued

    Purchase this Report (Price 3480 USD for a Single-User License)https://www.industryresearch.co/purchase/13856652

    Contact Us:

    Name: Ajay More

    Phone: US +1424 253 0807/ UK +44 203 239 8187

    Email ID: [email protected]

    Duct Attenuators Market Size by Regional Production Volume, Consumption Volume, Revenue and Growth Rate to 2026

    Breast Pumps Market Segmented by Technology, Component, Industry Size and Region – Growth, Trends and Forecasts (2019 – 2023)

    Peripheral Vascular Devices Market Report with Raw Material Analysis, Manufacturing Cost Structure, Application Size and Specification

    Thermal Imaging Market Research Report | by Size, Manufacturers, Opportunities, Challenges, Drivers, Growth, Countries, Revenue, and Forecast

    Emerging Neurorehabilitation Devices Market Aiming to Capture Largest Market Share with Developed Economies during 2018-2023